Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.09
+0.16 (2.24%)
May 28, 2026, 2:34 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $208.17 million as of May 28, 2026. Its market cap has decreased by -23.17% in one year.
Market Cap
208.17M
Enterprise Value
100.65M
1-Year Change
-23.17%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $208.17M, an increase of 25.35%. That is a compound annual growth rate of 9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 203.61M | 8.60% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 218.61M |
| Q32 Bio | 217.89M |
| Arcturus Therapeutics Holdings | 217.72M |
| NovaBridge Biosciences | 216.26M |
| Karyopharm Therapeutics | 202.51M |
| Korro Bio | 198.45M |
| Elicio Therapeutics | 198.31M |
| Precision BioSciences | 195.84M |